FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2742281800> ?p ?o ?g. }

• W2742281800 endingPage "312" @default.
• W2742281800 startingPage "302" @default.
• W2742281800 abstract "Platinum-based combination chemotherapy is standard treatment for the majority of patients with advanced non-small-cell lung cancer (NSCLC). The trial investigates the importance of the choice of platinum agent and dose of cisplatin in relation to patient outcomes.The three-arm randomised phase III trial assigned patients with chemo-naïve stage IIIB/IV NSCLC in a 1:1:1 ratio to receive gemcitabine 1250 mg/m2 on days 1 and 8 of a 3-week cycle with cisplatin 80 mg/m2 (GC80) or cisplatin 50 mg/m2 (GC50) or carboplatin AUC6 (GCb6) for a maximum of four cycles. Primary outcome measure was survival time, aiming to test for a difference between treatment arms and also assess non-inferiority with pre-defined margin selected as hazard ratio (HR) of 1.2. Secondary outcome measures included response rate, adverse events and quality of life (QoL).The trial recruited 1363 patients. Survival time differed significantly across the three treatment arms (p = 0.046) with GC50 worst with median 8.2 months compared to 9.5 for GC80 and 10.0 for GCb6. HRs (adjusted) for GC50 compared to GC80 was 1.13 (95% confidence interval [CI] 0.99-1.29) and for GC50 compared to GCb6 was 1.23 (95% CI: 1.08-1.41). GCb6 was significantly non-inferior to GC80 (HR = 0.93, upper limit of one-sided 95% CI 1.04). Adjusting for QoL did not change the findings. Best objective response rates were 29% (GC80), 20% (GC50) and 27% (GCb6), p < 0.007. There were more dose reductions and treatment delays in the GCb6 arm and more adverse events (60% with at least one grade 3-4 compared to 43% GC80 and 30% GC50).In combination with gemcitabine, carboplatin at AUC6 is not inferior to cisplatin at 80 mg/m2 in terms of survival. Carboplatin was associated with more adverse events and not with better quality of life. Cisplatin at the lower dose of 50 mg/m2 has worse survival which is not compensated by better quality of life. CLINICALTRIALS.NCT00112710.2004-003868-30.CRUK/04/009." @default.
• W2742281800 created "2017-08-17" @default.
• W2742281800 creator A5001518016 @default.
• W2742281800 creator A5004384935 @default.
• W2742281800 creator A5005554940 @default.
• W2742281800 creator A5006628495 @default.
• W2742281800 creator A5010405819 @default.
• W2742281800 creator A5033519199 @default.
• W2742281800 creator A5034005852 @default.
• W2742281800 creator A5034748028 @default.
• W2742281800 creator A5035278067 @default.
• W2742281800 creator A5050212900 @default.
• W2742281800 creator A5055057910 @default.
• W2742281800 creator A5057287090 @default.
• W2742281800 creator A5064249688 @default.
• W2742281800 creator A5067545092 @default.
• W2742281800 creator A5073547589 @default.
• W2742281800 creator A5074685337 @default.
• W2742281800 creator A5075003980 @default.
• W2742281800 creator A5085257858 @default.
• W2742281800 creator A5091450277 @default.
• W2742281800 date "2017-09-01" @default.
• W2742281800 modified "2023-09-27" @default.
• W2742281800 title "Carboplatin versus two doses of cisplatin in combination with gemcitabine in the treatment of advanced non-small-cell lung cancer: Results from a British Thoracic Oncology Group randomised phase III trial" @default.
• W2742281800 cites W1907795058 @default.
• W2742281800 cites W1963767762 @default.
• W2742281800 cites W1967628954 @default.
• W2742281800 cites W1970065450 @default.
• W2742281800 cites W2010357278 @default.
• W2742281800 cites W2018802677 @default.
• W2742281800 cites W2037139573 @default.
• W2742281800 cites W2099725888 @default.
• W2742281800 cites W2109567704 @default.
• W2742281800 cites W2113003672 @default.
• W2742281800 cites W2116996913 @default.
• W2742281800 cites W2125065061 @default.
• W2742281800 cites W2125665528 @default.
• W2742281800 cites W2131593307 @default.
• W2742281800 cites W2136503777 @default.
• W2742281800 cites W2139248078 @default.
• W2742281800 cites W2144330816 @default.
• W2742281800 cites W2145754274 @default.
• W2742281800 cites W2151408213 @default.
• W2742281800 cites W2151518427 @default.
• W2742281800 cites W2166399931 @default.
• W2742281800 cites W2167571044 @default.
• W2742281800 cites W2338394838 @default.
• W2742281800 cites W2473786944 @default.
• W2742281800 cites W2527905628 @default.
• W2742281800 cites W2626223149 @default.
• W2742281800 cites W4238604577 @default.
• W2742281800 cites W4239714259 @default.
• W2742281800 cites W4297939389 @default.
• W2742281800 doi "https://doi.org/10.1016/j.ejca.2017.05.037" @default.
• W2742281800 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5597318" @default.
• W2742281800 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28780466" @default.
• W2742281800 hasPublicationYear "2017" @default.
• W2742281800 type Work @default.
• W2742281800 sameAs 2742281800 @default.
• W2742281800 citedByCount "17" @default.
• W2742281800 countsByYear W27422818002018 @default.
• W2742281800 countsByYear W27422818002019 @default.
• W2742281800 countsByYear W27422818002020 @default.
• W2742281800 countsByYear W27422818002021 @default.
• W2742281800 countsByYear W27422818002022 @default.
• W2742281800 countsByYear W27422818002023 @default.
• W2742281800 crossrefType "journal-article" @default.
• W2742281800 hasAuthorship W2742281800A5001518016 @default.
• W2742281800 hasAuthorship W2742281800A5004384935 @default.
• W2742281800 hasAuthorship W2742281800A5005554940 @default.
• W2742281800 hasAuthorship W2742281800A5006628495 @default.
• W2742281800 hasAuthorship W2742281800A5010405819 @default.
• W2742281800 hasAuthorship W2742281800A5033519199 @default.
• W2742281800 hasAuthorship W2742281800A5034005852 @default.
• W2742281800 hasAuthorship W2742281800A5034748028 @default.
• W2742281800 hasAuthorship W2742281800A5035278067 @default.
• W2742281800 hasAuthorship W2742281800A5050212900 @default.
• W2742281800 hasAuthorship W2742281800A5055057910 @default.
• W2742281800 hasAuthorship W2742281800A5057287090 @default.
• W2742281800 hasAuthorship W2742281800A5064249688 @default.
• W2742281800 hasAuthorship W2742281800A5067545092 @default.
• W2742281800 hasAuthorship W2742281800A5073547589 @default.
• W2742281800 hasAuthorship W2742281800A5074685337 @default.
• W2742281800 hasAuthorship W2742281800A5075003980 @default.
• W2742281800 hasAuthorship W2742281800A5085257858 @default.
• W2742281800 hasAuthorship W2742281800A5091450277 @default.
• W2742281800 hasBestOaLocation W27422818001 @default.
• W2742281800 hasConcept C126322002 @default.
• W2742281800 hasConcept C141071460 @default.
• W2742281800 hasConcept C143998085 @default.
• W2742281800 hasConcept C197934379 @default.
• W2742281800 hasConcept C207103383 @default.
• W2742281800 hasConcept C2776256026 @default.
• W2742281800 hasConcept C2776694085 @default.
• W2742281800 hasConcept C2778239845 @default.
• W2742281800 hasConcept C2780258809 @default.
• W2742281800 hasConcept C2781451048 @default.
• W2742281800 hasConcept C44249647 @default.

• next